Valson Industrie (530459)

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Price-to-book at 0.84 provides asset support below stated book value of ₹34.18
• Piotroski F-Score of 6/9 indicates reasonably healthy financial signals
• Reported profit growth of 128.57% and PEG of 0.20 show potential earnings inflection, albeit from a small base
• Small market cap of ₹22 Cr offers asymmetry if a turnaround actually materialises

Concerns

• Sales declined by 27.64%, and the latest quarter reported net profit of ₹0 Cr, showing weak current earnings power
• ROE of 2.88% and ROCE of 4.47% are far below acceptable returns on equity and capital
• P/E of 25.51 is expensive relative to near-zero earnings, and there is no dividend yield
• Promoter holding and debt-to-equity are not disclosed, limiting confidence in governance and leverage

AI Analysis

At ₹28.75, Valson Industrie trades at a 16% discount to book value of ₹34.18. That catches my eye, but I quickly ask: is this a cheap asset protected by earnings power, or a value trap? The numbers are mixed. Sales fell nearly 28% in the latest year; the most recent quarter managed ₹27 Cr in sales but net profit was ₹0 Cr. That is not a business compounding intrinsic value. ROE is just 2.88%, and ROCE is 4.47%—far below what I would demand unless I am buying it as a recoverable asset. The reported profit growth of 128.57% sounds exciting, but from a tiny or inconsistent base it can mislead; the zero quarterly profit is a reminder. At a P/E of 25.51, the market is paying a premium for what are historically low earnings. The Piotroski F-Score of 6/9 gives slight comfort on financial health, but with no debt-to-equity data provided, I cannot assess leverage confidently. There is no dividend to reward me while I wait. This is not a wonderful business; it looks like a commodity textile operation with weak returns. Graham would say pay a margin of safety, and the P/B below 1 gives some asset support. But asset value only wins if management redeploys capital or the cycle turns. I would treat this as a small, speculative asset play, not a core compounder. I want sales to stabilise, quarterly profits to return, and book value to hold above ₹34 before believing this is a genuine turnaround. Until then, the price is cheap, but the earnings do not justify enthusiasm.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer